Skip to main content

Research

Publications

OBRI researchers publish findings in leading peer-reviewed rheumatology journals. Below is a selection of recent publications.

Note: This list is a representative selection of OBRI publications. For a complete list, please contact us at Angela.Cesta@uhn.ca.

2026

Impact of Rheumatoid Arthritis Treatment Classes on Cardiovascular, Thromboembolic, Cancer Outcomes, and All-Cause Mortality: A Population-Based Cohort Study

Movahedi M, Cesta A, Aydin SZ, Akhavan P, Kendzerska T, Bombardier C, Kuriya B, on behalf of OBRI Investigators

Inflamm. J. · 2026

DOI: 10.3390/inflammj1010002

RACardiovascular
Persistence and effectiveness of upadacitinib and TNFi for rheumatoid arthritis using pooled data from Canadian and Swiss registries

Choquette D, Finckh A, Rubbert-Roth A, Coupal L, Li X, Aydin SZ, et al.

Rheumatology (Oxford) · 2026

DOI: 10.1093/rheumatology/keag301

RATreatment

Treatment Sequences and Lines of Therapy in Rheumatoid Arthritis: A Real-World Evaluation of Retention and Effectiveness

Movahedi M, Kuriya B, Cesta A, Li X, Aydin SZ, Bombardier C, Akhavan P, OBRI investigators

Clinical and Experimental Rheumatology · 2026

RATreatment

COVID-19 in Rheumatoid Arthritis: prevalence, hospital admission, and risk of all-cause mortality before and after COVID-19 pandemic

Movahedi M, Li X, Cesta A, Bombardier C, Hepworth E, Aydin S, OBRI investigators

Clinical and Experimental Rheumatology · 2026

RACOVID-19
Defining Difficult-to-Treat Rheumatoid Arthritis in Routine Care: Comparative Performance of Published Criteria and Description of Early and Late D2T-RA Phenotypes

Atta RZ, Movahedi M, Cesta A, Akhavan P, Thorne C, Pope J, et al.

Arthritis Care Res (Hoboken) · 2026

DOI: 10.1002/acr.80161

RAClinical

Impact of Coexisting Gout on Disease Activity in Rheumatoid Arthritis: Data from the Ontario Best Practices Research Initiative (OBRI)

Kwok T, Movahedi M, Cesta A, Akhavan A, Thorne C, Pope J, Lau A, Mirza R, Hepworth E, Chow A, Aydin S, Kuriya B

Journal of Rheumatology · 2026(revised version under review)

RAComorbidities

2025

Healthcare utilization and cost of herpes zoster infection in patients with rheumatoid arthritis: A retrospective cohort study

Movahedi M, Cesta A, Li X, Tatangelo M, Pope JE, Bombardier C, OBRI Investigators

J Rheumatol · 2025

DOI: 10.3899/jrheum.2024-0911

RAComorbidities
Healthcare utilization among patients with rheumatoid arthritis, with and without herpes zoster, a retrospective administrative data linked cohort study

Movahedi M, Cesta A, Li X, Tatangelo MR, Bombardier C, OBRI investigators

PLoS One · 2025

DOI: 10.1371/journal.pone.0323229

RAComorbidities

2024

Functional disability and disease activity are affected by social determinants of health in patients with rheumatoid arthritis

Movahedi M, Cui K, Tomlinson G, Cesta A, Li X, Bombardier C

Clin Rheumatol · 2024

DOI: 10.1007/s10067-024-07148-3

RAPopulation Health
Impact of anti-rheumatic treatment on the individual components of the ACR composite score in patients with rheumatoid arthritis: real-world data

Movahedi M, Choquette D, Coupal L, Keystone E, Bombardier C, Bessette L

Clin Exp Rheumatol · 2024

DOI: 10.55563/clinexprheumatol/6qobnr

RATreatment
Retention of triple therapy with methotrexate, sulfasalazine, and hydroxychloroquine compared to combination methotrexate and leflunomide in rheumatoid arthritis

Bhavsar SV, Movahedi M, Cesta A, Pope JE, Bombardier C

Joint Bone Spine · 2024

DOI: 10.1016/j.jbspin.2024.105732

RATreatment
Biologics initiation in moderate versus severe rheumatoid arthritis: real-world experience from a Canadian registry

Guo N, Li X, Movahedi M, Cesta A, Bombardier C

Clin Exp Rheumatol · 2024

DOI: 10.55563/clinexprheumatol/mpevid

RABiologics

2023

Factors affecting the discrepancy between patient and physician global assessment in early rheumatoid arthritis: The Ontario Best Practices Research Initiative

Akhavan PS, Movahedi M, Cesta A, Bombardier C, OBRI investigators

Clin Exp Rheumatol · 2023

DOI: 10.55563/clinexprheumatol/r7b8go

RAPatient Outcomes
Impact of the COVID-19 pandemic on patients with rheumatoid arthritis: data from the Ontario Best Practices Research Initiative (OBRI)

Wong-Pack M, Hepworth E, Movahedi M, Kuriya B, Aydin SZ, et al.

Rheumatol Adv Pract · 2023

DOI: 10.1093/rap/rkad042

RACOVID-19
Discontinuation of tofacitinib and TNF inhibitors in patients with rheumatoid arthritis: analysis of pooled data from two registries in Canada

Movahedi M, Choquette D, Coupal L, Cesta A, Li X, Keystone EC, Bombardier C, OBRI Investigators

BMJ Open · 2023

DOI: 10.1136/bmjopen-2022-063198

RATreatment
Medical cannabis use by rheumatology patients in routine clinical care: results from the Ontario Best Practices Research Initiative

Rampakakis E, Thorne C, Cesta A, Movahedi M, Bombardier C, et al.

Clin Exp Rheumatol · 2023

DOI: 10.55563/clinexprheumatol/b85xu5

RAClinical

2022

Differential influence of clinical disease activity index components based on disease state in rheumatoid arthritis patients: real-world results from the Ontario Best Practices Research Initiative

Keystone E, Movahedi M, Cesta A, Bombardier C, Sampalis JS, Rampakakis E

Clin Exp Rheumatol · 2022

DOI: 10.55563/clinexprheumatol/86frzq

RADisease Activity
Disease activity trajectories for early and established rheumatoid arthritis: Real-world data from a rheumatoid arthritis cohort

Movahedi M, Cesta A, Li X, Bombardier C, OBRI investigators

PLoS One · 2022

DOI: 10.1371/journal.pone.0274264

RADisease Activity
Physician-and patient-reported effectiveness are similar for tofacitinib and TNFi in rheumatoid arthritis: Data from a rheumatoid arthritis registry

Movahedi M, Cesta A, Li X, Keystone EC, Bombardier C, OBRI Investigators

J Rheumatol · 2022

DOI: 10.3899/jrheum.211066

RATreatment
Heterogeneity in patient characteristics and differences in treatment across 4 Canadian rheumatoid arthritis cohorts

Hazlewood GS, Bombardier C, Li X, Movahedi M, Barber CEH, et al.

J Rheumatol · 2022

DOI: 10.3899/jrheum.201688

RAPopulation Health

2021

Cardiovascular risk factors are negatively associated with rheumatoid arthritis disease outcomes

Cui K, Movahedi M, Bombardier C, Kuriya B

Ther Adv Musculoskelet Dis · 2021

DOI: 10.1177/1759720X20981217

RACardiovascular
Time to remission in swollen joints is far faster than patient reported outcomes in rheumatoid arthritis: results from the Ontario Best Practices Research Initiative (OBRI)

Pope J, Rampakakis E, Movahedi M, Cesta A, Sampalis JS, Bombardier C, for OBRI investigators

Rheumatology (Oxford) · 2021

DOI: 10.1093/rheumatology/keaa343

RAPatient Outcomes

2020

Patient, rheumatologist, and therapist perspectives on the implementation of an allied health rheumatology triage (AHRT) initiative in Ontario rheumatology clinics

Fullerton L, Brooks S, Sweezie R, Ahluwalia V, Bombardier C, Gigliardi A

Pragmat Obs Res · 2020

DOI: 10.2147/POR.S213966

RAClinical
Discontinuation of biologic therapy due to lack/loss of response and adverse events is similar between TNFi and non-TNFi class: Results from a real-world rheumatoid arthritis cohort

Movahedi M, Hepworth E, Mirza R, Cesta A, Larche M, Bombardier C

Semin Arthritis Rheum · 2020

DOI: 10.1016/j.semarthrit.2020.06.020

RABiologics
Towards defining primary and secondary non-response in rheumatoid arthritis patients treated with anti-TNFs: Results from the BioTRAC and OBRI registries

Keystone E, Rampakakis E, Movahedi M, Cesta A, Stutz M, et al.

J Rheumatol · 2020

DOI: 10.3899/jrheum.190102

RABiologics

2019

Frailty and risk of osteoporotic fractures in patients with rheumatoid arthritis: Data from the Ontario Biologics Research Initiative

Li G, Chen M, Li X, Cesta A, Lau A, Thabane L, Adachi JD, Tian J, Bombardier C

Bone · 2019

DOI: 10.1016/j.bone.2019.06.006

RAComorbidities
Impact of residential area on the management of rheumatoid arthritis patients initiating their first biologic DMARD: Results from the Ontario Best Practices Research Initiative (OBRI)

Movahedi M, Joshi R, Rampakakis E, Thorne C, Cesta A, Sampalis JS, Bombardier C, on behalf of Other OBRI Investigators

Medicine (Baltimore) · 2019

DOI: 10.1097/MD.0000000000015517

RAPopulation Health

2018

ACPA and RF as predictors of sustained clinical remission in rheumatoid arthritis patients: results from the Ontario Best Practices Research Initiative (OBRI)

Pope J, Movahedi M, Rampakakis E, Cesta A, Sampalis JS, Bombardier C, and OBRI investigators

RMD Open · 2018

DOI: 10.1136/rmdopen-2018-000738

RAClinical
RAPatient Outcomes

Treatment patterns in rheumatoid arthritis after discontinuation of methotrexate: Data from the Ontario Best Practices Research Initiative (OBRI)

Pope J, Rampakakis E, Movahedi M, Cesta A, Couto S, Sampalis J, Bombardier C, and OBRI Investigators

Clinical and Experimental Rheumatology · 2018

RATreatment

2017

Predictors of patient decision to discontinue anti-rheumatic medication in patients with rheumatoid arthritis: Results from the Ontario Best Practices Initiative

Ahluwalia V, Rampakakis E, Movahedi M, Cesta A, Li X, et al.

Clinical Rheumatology · 2017

DOI: 10.1007/s10067-017-3805-4

RATreatment

2015

The influence of age at disease onset on disease activity and disability: results from the Ontario Best Practices Research Initiative

Ruban TN, Jacob B, Pope JE, Keystone EC, Bombardier C, Kuriya B

Clin Rheumatol · 2015

DOI: 10.1007/s10067-015-3031-x

RAClinical
Trends in excess mortality among patients with rheumatoid arthritis in Ontario, Canada

Widdifield J, Bernatsky S, Paterson MJ, Tomlinson G, Tu K, et al.

Arthritis Care Res (Hoboken) · 2015

DOI: 10.1002/acr.22553

RAPopulation Health

2014

An administrative data validation study of the accuracy of algorithms for identifying rheumatoid arthritis: The influence of the reference standard on algorithm performance

Widdifield J, Bombardier C, Bernatsky S, Paterson JM, Green D, et al.

BMC Musculoskeletal Disorders · 2014

RAMethodology
The Epidemiology of rheumatoid arthritis in Ontario, Canada

Widdifield J, Paterson JM, Bernatsky S, Tu K, Tomlinson G, et al.

Arthritis Rheumatol · 2014

DOI: 10.1002/art.38306

RAEpidemiology
Access to rheumatologists among patients with newly diagnosed rheumatoid arthritis in a Canadian universal public healthcare system

Widdifield J, Paterson JM, Bernatsky S, Tu K, Thorne JC, et al.

BMJ Open · 2014

DOI: 10.1136/bmjopen-2013-003888

RAPopulation Health

2013

The rising burden of rheumatoid arthritis surpasses rheumatology supply in Ontario

Widdifield J, Paterson JM, Bernatsky S, Tu K, Thorne JC, et al.

Can J Public Health · 2013

DOI: 10.17269/cjph.104.4115

RAEpidemiology
Serious infections in a population-based cohort of 86,039 seniors with rheumatoid arthritis

Widdifield J, Bernatsky S, Paterson JM, Gunraj N, Thorne JC, et al.

Arthritis Care Res (Hoboken) · 2013

DOI: 10.1002/acr.21812

RAComorbidities

Accuracy of Canadian health administrative databases in identifying patients with rheumatoid arthritis: A validation study using the medical records of rheumatologists

Widdifield J, Bernatsky S, Paterson JM, Tu K, Ng R, et al.

Arthritis Care Res (Hoboken) · 2013

RAMethodology